We revealed that high expression of KRT19 (median values as the cutoff) was significantly correlated with good outcomes in breast cancer, whereas a poor prognosis was associated with colon cancer patients with high KRT19 expression (Figure 3a,b). This evidence concerns the gene KRT19 and breast carcinoma.